Related Experiment Video
Updated: Jan 12, 2026
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Role of platelet-related parameters in prediction of development and severity of preeclampsia (PE): an observational
Mukta Agarwal1, Shruti Singh1, Divendu Bhushan2
1Department of Obstetrics and Gynaecology, AIIMS Patna, Bihar, India.
Insights
Plateletcrit (PCT) and neutrophil-to-lymphocyte ratio (NLR) may help predict preeclampsia (PE) in early pregnancy. Mean platelet volume (MPV) showed association in late pregnancy, suggesting potential for risk stratification.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Maternal-Fetal Medicine
Background:
- Preeclampsia (PE) is a leading cause of maternal and fetal complications.
- Effective screening tools for early PE detection are lacking.
- Platelet indices and inflammatory markers are potential biomarkers for PE.
Purpose of the Study:
- To investigate the predictive value of platelet count (PC), mean platelet volume (MPV), plateletcrit (PCT), platelet distribution width (PDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for PE development and severity.
Main Methods:
- Prospective observational cohort study of pregnant women from early gestation.
- Measurement of platelet parameters and ratios at 10-14, 24-28, and 32-36 weeks.
- Statistical analysis using chi-square tests, t-tests, and logistic regression.
Main Results:
- Preeclampsia developed in 9.3% of 728 participants.
- Significant differences in PCT and NLR were observed in early pregnancy (10-14 weeks).
- PCT showed differences in mid-trimester, and MPV was elevated in late pregnancy (32-36 weeks).
Conclusions:
- PCT and NLR are associated with PE in early pregnancy.
- MPV is associated with PE in late pregnancy.
- These markers may aid in PE risk stratification, but further validation is needed for routine screening.
Objectives:
Preeclampsia (PE) is a major contributor to maternal and foetal morbidity and mortality. Early identification of women at risk is crucial for timely intervention, yet a cost-effective and reliable screening tool remains unavailable. This study aimed to evaluate the role of platelet-related parameters-platelet count (PC), mean platelet volume (MPV), plateletcrit (PCT), platelet distribution width (PDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR)-in predicting the development and severity of PE.
Methods:
This prospective observational cohort study was conducted at AIIMS Patna between January and November 2021. Pregnant women enrolled before 14 weeks of gestation were followed throughout pregnancy. Platelet parameters were measured at three gestational intervals: 10 to 14 weeks, 24 to 28 weeks, and 32 to 36 weeks. Data were analysed using SPSS v22, employing chi-square tests, t-tests, and logistic regression.
Results:
Among 728 participants, 9.3% developed PE. Risk was significantly higher in primigravida women (p = 0.040), twin pregnancies (p = 0.027), and those with low educational status (p = 0.006). Significant differences were observed in PCT (p = 0.000) and NLR (p = 0.009) at 10 to 14 weeks, PCT (p = 0.034) at mid-trimester, and MPV (p = 0.005) at 32 to 36 weeks. Although MPV showed a consistent association with PE across trimesters, regression models did not achieve overall statistical significance.
Conclusion:
Platelet indices, particularly PCT and NLR, demonstrated a significant association with PE in early pregnancy, while MPV was significantly elevated in late pregnancy. These findings suggest potential utility in risk stratification, though further studies are required to validate their predictive value before routine use in early screening.
